157 related articles for article (PubMed ID: 35062212)
1. Activity of Galidesivir in a Hamster Model of SARS-CoV-2.
Taylor R; Bowen R; Demarest JF; DeSpirito M; Hartwig A; Bielefeldt-Ohmann H; Walling DM; Mathis A; Babu YS
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062212
[TBL] [Abstract][Full Text] [Related]
2. An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral.
Julander JG; Demarest JF; Taylor R; Gowen BB; Walling DM; Mathis A; Babu YS
Antiviral Res; 2021 Nov; 195():105180. PubMed ID: 34551346
[TBL] [Abstract][Full Text] [Related]
3. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.
Eyer L; Nougairède A; Uhlířová M; Driouich JS; Zouharová D; Valdés JJ; Haviernik J; Gould EA; De Clercq E; de Lamballerie X; Ruzek D
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142664
[TBL] [Abstract][Full Text] [Related]
4. Persimmon-derived tannin has antiviral effects and reduces the severity of infection and transmission of SARS-CoV-2 in a Syrian hamster model.
Furukawa R; Kitabatake M; Ouji-Sageshima N; Suzuki Y; Nakano A; Matsumura Y; Nakano R; Kasahara K; Kubo K; Kayano SI; Yano H; Ito T
Sci Rep; 2021 Dec; 11(1):23695. PubMed ID: 34880383
[TBL] [Abstract][Full Text] [Related]
5. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
Front Immunol; 2022; 13():811430. PubMed ID: 35250984
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Safety of the Nucleoside Analog Antiviral Drug Galidesivir Administered to Healthy Adult Subjects.
Mathis A; Collins D; Dobo S; Walling DM; Sheridan WP; Taylor R
Clin Pharmacol Drug Dev; 2022 Apr; 11(4):467-474. PubMed ID: 35182042
[TBL] [Abstract][Full Text] [Related]
8. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.
Driouich JS; Cochin M; Lingas G; Moureau G; Touret F; Petit PR; Piorkowski G; Barthélémy K; Laprie C; Coutard B; Guedj J; de Lamballerie X; Solas C; Nougairède A
Nat Commun; 2021 Mar; 12(1):1735. PubMed ID: 33741945
[TBL] [Abstract][Full Text] [Related]
9. In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase.
Celik I; Erol M; Duzgun Z
Mol Divers; 2022 Feb; 26(1):279-292. PubMed ID: 33765239
[TBL] [Abstract][Full Text] [Related]
10. Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters.
Westover JB; Mathis A; Taylor R; Wandersee L; Bailey KW; Sefing EJ; Hickerson BT; Jung KH; Sheridan WP; Gowen BB
Antiviral Res; 2018 Aug; 156():38-45. PubMed ID: 29864447
[TBL] [Abstract][Full Text] [Related]
11. GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition.
Bestion E; Zandi K; Belouzard S; Andreani J; Lepidi H; Novello M; Rouquairol C; Baudoin JP; Rachid M; La Scola B; Mege JL; Dubuisson J; Schinazi RF; Mezouar S; Halfon P
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062337
[TBL] [Abstract][Full Text] [Related]
12. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
[TBL] [Abstract][Full Text] [Related]
13. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
[TBL] [Abstract][Full Text] [Related]
14. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection.
Sohn SY; Hearing J; Mugavero J; Kirillov V; Gorbunova E; Helminiak L; Mishra S; Mackow E; Hearing P; Reich NC; Kim HK
mBio; 2021 Dec; 12(6):e0275621. PubMed ID: 34724828
[TBL] [Abstract][Full Text] [Related]
15. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
Kaptein SJF; Jacobs S; Langendries L; Seldeslachts L; Ter Horst S; Liesenborghs L; Hens B; Vergote V; Heylen E; Barthelemy K; Maas E; De Keyzer C; Bervoets L; Rymenants J; Van Buyten T; Zhang X; Abdelnabi R; Pang J; Williams R; Thibaut HJ; Dallmeier K; Boudewijns R; Wouters J; Augustijns P; Verougstraete N; Cawthorne C; Breuer J; Solas C; Weynand B; Annaert P; Spriet I; Vande Velde G; Neyts J; Rocha-Pereira J; Delang L
Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26955-26965. PubMed ID: 33037151
[TBL] [Abstract][Full Text] [Related]
16. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
[TBL] [Abstract][Full Text] [Related]
19. Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.
Silva Arouche TD; Reis AF; Martins AY; S Costa JF; Carvalho Junior RN; J C Neto AM
J Nanosci Nanotechnol; 2020 Dec; 20(12):7311-7323. PubMed ID: 32711596
[TBL] [Abstract][Full Text] [Related]
20. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters.
Yuan S; Wang R; Chan JF; Zhang AJ; Cheng T; Chik KK; Ye ZW; Wang S; Lee AC; Jin L; Li H; Jin DY; Yuen KY; Sun H
Nat Microbiol; 2020 Nov; 5(11):1439-1448. PubMed ID: 33028965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]